CLASS II ONGOING Device recall · Reported 4 Dec 2024 · FDA Enforcement Report

Kreatech PapV-16, Flu labeled ISH probe recalled

Kreatech Biotechnology is recalling Kreatech PapV-16, Flu labeled ISH probe, to detect presence of HPV-16 DNA inserts in, distributed in Florida, New York. The recall was initiated on 1 Nov 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: (01)08718858480241 Lot Number: 00088454
Quantity recalled23 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0522-2025
FDA event ID
95668
Recalling firm
Kreatech Biotechnology, Amsterdam
Classification
Class II
Status
Ongoing
Recall initiated
1 Nov 2024
FDA classified
22 Nov 2024
Reported
4 Dec 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

1 Nov 2024Recall initiated by company
22 Nov 2024Classified by FDA+21 days
4 Dec 2024Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The DNA fragments for this specific lot number are too large, resulting in potential background around the cells due to suboptimal hybridization. An absence of signal could also be observed as a result of the suboptimal hybridization of the larger DNA fragments. The user may interpret potential background as a false positive result and an absence of signal as a false negative result, if proper positive and negative controls are not included.

Product as listed by the FDA

Kreatech PapV-16, Flu labeled ISH probe, to detect presence of HPV-16 DNA inserts in human tissue, Model Number 40V016V495

Where it was distributed

US States: FL, NY

FloridaNew York

Questions about this recall

Why was it recalled?

The DNA fragments for this specific lot number are too large, resulting in potential background around the cells due to suboptimal hybridization. An absence of signal could also be observed as a result of the suboptimal hybridization of the larger DNA fragments. The user may interpret potential background as a false positive result and an absence of signal as a false negative result, if proper positive and negative controls are not included.

Which lots are affected?

UDI-DI: (01)08718858480241 Lot Number: 00088454

Where was it sold?

US States: FL, NY

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other Other Medical Devices recalls

All 13,908